These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 17929140)
41. Interstitial lung disease associated with leflunomide. Ito S; Sumida T Intern Med; 2004 Dec; 43(12):1103-4. PubMed ID: 15645640 [No Abstract] [Full Text] [Related]
42. Leflunomide for active rheumatoid arthritis. Ferraccioli GF; De Vita S Lancet; 1999 May; 353(9167):1883; author reply 1883-4. PubMed ID: 10359440 [No Abstract] [Full Text] [Related]
43. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate. Gupta R; Gupta SK MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235 [No Abstract] [Full Text] [Related]
44. [Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review]. Molina Molina MI; Pinochet Paiva CM; Quezada Morales JI Medwave; 2015 Dec; 15(11):e6350. PubMed ID: 26819061 [TBL] [Abstract][Full Text] [Related]
45. Severe pancytopenia following etanercept administration in rheumatoid arthritis. Martínez Santana V; Izquierdo Navarro M; Calleja Hernández MÁ; Sánchez Sánchez T; Sainz Gil M Int J Rheum Dis; 2012 Aug; 15(4):e78-9. PubMed ID: 22898233 [No Abstract] [Full Text] [Related]
46. Acute hepatitis associated to leflunomide in a patient with rheumatoid arthritis. Chávez-López MA; Ramírez-González A; Martínez-Guevara MA Gastroenterol Hepatol; 2007; 30(7):430. PubMed ID: 17692207 [No Abstract] [Full Text] [Related]
47. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice. Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR Br J Clin Pharmacol; 2004 Aug; 58(2):201-8. PubMed ID: 15255803 [TBL] [Abstract][Full Text] [Related]
48. Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide. Martinez-Taboada VM; Rodriguez-Valverde V; Gonzalez-Vilchez F; Armijo JA Rheumatology (Oxford); 2004 Nov; 43(11):1451-3. PubMed ID: 15501999 [No Abstract] [Full Text] [Related]
49. Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination. Toth P; Bernd R Rev Bras Reumatol; 2014; 54(2):152-4. PubMed ID: 24878863 [TBL] [Abstract][Full Text] [Related]
54. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate. Wolfe F; Michaud K; Stephenson B; Doyle J J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927 [TBL] [Abstract][Full Text] [Related]
55. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide? Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770 [TBL] [Abstract][Full Text] [Related]
56. Subacute cutaneous lupus erythematosus associated with leflunomide. Elias AR; Tam CC; David-Bajar KM Cutis; 2005 Sep; 76(3):189-92. PubMed ID: 16268263 [TBL] [Abstract][Full Text] [Related]